Diabetes and end-stage renal disease; a review article on new concepts SB Ghaderian, F Hayati, S Shayanpour, SSB Mousavi Journal of renal injury prevention 4 (2), 28, 2015 | 289 | 2015 |
Prevention of cisplatin nephrotoxicity F Hayati, M Hossainzadeh, S Shayanpour, Z Abedi-Gheshlaghi, ... Journal of nephropharmacology 5 (1), 57, 2016 | 86 | 2016 |
Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial H Shahbazian, H Shahbazian, A Zafar Mohtashami, A Zafar Mohtashami, ... Nefrologia 31 (1), 58-65, 2011 | 62 | 2011 |
Survival at 1, 3, and 5 years in diabetic and nondiabetic patients on hemodialysis MSSE BELADI, F Hayati, AMJ Alemzadeh, E Valavi, B Cheraghian, ... IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD) 4 (1), 74-77, 2010 | 60 | 2010 |
Evaluation of acquired cystic kidney disease in patients on hemodialysis with ultrasonography MSSE BELADI, M Sametzadeh, F Hayati, SM Fatemi IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD) 4 (3), 223-226, 2010 | 50 | 2010 |
Renal biopsy findings in Iran: case series report from a referral kidney center S Ossareh, M Asgari, E Abdi, H Nejad-Gashti, Y Ataipour, S Aris, ... International urology and nephrology 42, 1031-1040, 2010 | 49 | 2010 |
Arterio-Venous fistula recirculation in hemodialysis: causes and prevalences SSB Mousavi Shiraz E-Medical Journal 11 (4), 219-224, 2010 | 42 | 2010 |
Efecto de la DDVAP intranasal en la prevención de la hipotensión durante la hemodiálisis SS Beladi-Mousavi, M Beladi-Mousavi, F Hayati, M Talebzadeh Nefrología (Madrid) 32 (1), 89-93, 2012 | 39 | 2012 |
Efecto de la DDVAP intranasal en la prevención de la hipotensión durante la hemodiálisis SS Beladi-Mousavi, M Beladi-Mousavi, F Hayati, M Talebzadeh Nefrología (Madrid) 32 (1), 89-93, 2012 | 39 | 2012 |
Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis SSB Mousavi, F Hayati, E Valavi, F Rekabi, MB Mousavi Saudi Journal of Kidney Diseases and Transplantation 26 (2), 392-397, 2015 | 37 | 2015 |
The prevalence of malnutrition in hemodialysis patients A Ghorbani, F Hayati, M Karandish, S Sabzali Journal of Renal Injury Prevention 9 (2), e15-e15, 2020 | 36 | 2020 |
The protective effect of theophyline in cisplatin nephrotoxicity SSB Mousavi, MH Zadeh, H Shahbazian, A Khanzadeh, F Hayati, ... Saudi Journal of Kidney Diseases and Transplantation 25 (2), 333-337, 2014 | 23 | 2014 |
What is the Difference between Causes of ESRD in Iran and Developing Countries? SSB Mousavi, M Mousavi Shiraz E-Medical Journal 13 (2), 2012 | 15 | 2012 |
Pulmonary hypertension among patients undergoing hemodialysis F Hayati, SSB Mousavi, SMM Movahed, MM Bushehri Journal of Renal Injury Prevention 6 (2), 122, 2017 | 14 | 2017 |
The relationship between chronic kidney disease and cancer SM Mousavi Movahhed, SS Beladi Mousavi, F Hayati, S Shayanpour, ... Journal of Nephropathology 7 (3), 115-116, 2018 | 11 | 2018 |
Survival at 1, 3, and 5 Years in Diabetic and Nondiabetic Hemodialysis Patients SS Beladi Musavi, F Hayati, MJ Alemzadeh Ansari, E Valav, ... Iran J Kidney Dis 4 (1), 74-7, 2010 | 11 | 2010 |
Epidemiology of hepatitis C virus infection in ESRD patients in Khuzestan province, Iran SSB Mousavi, E Hajiani, F Hayati, SJ Hashemi, A Shayesteh, ... Shiraz E-Medical Journal 13 (3), 135-140, 2012 | 10 | 2012 |
DO WE NEED TO SCREEN OUR PATIENTS FOR EBV IGG ANTIBODY BEFORE KIDNEY TRANSPLAN TATION? MSSE BELADI, F Hayati THE JOURNAL OF NEPHRO-UROLOGY MONTHLY 3 (2), 122-124, 2011 | 9 | 2011 |
Protective effect of forced hydration with isotonic saline, potassium chloride and magnesium sulfate on cisplatin nephrotoxicity: an initial evaluation MSS BELADI, M Hossainzadeh, A Khanzadeh, F Hayati, MM BELADI, ... ASIA PACIFIC JOURNAL OF MEDICAL TOXICOLOGY (APJMT) 2 (4), 136-139, 2013 | 8 | 2013 |
Prevalence of impaired renal function and determinants in the southwest of Iran S Alvand, F Abolnezhadian, S Alatab, Z Mohammadi, F Hayati, M Noori, ... BMC nephrology 22 (1), 276, 2021 | 7 | 2021 |